About Lurbinectedin
            
            Class: | Antineoplastic agent, specifically a DNA-binding agent  
Use: | Treatment of adult patients with metastatic small cell lung cancer (SCLC) who have progressed on or after platinum-based chemotherapy and at least one other line of therapy  
Adult dose: | 3.2 mg/m² administered as an intravenous infusion over 60 minutes on day 1 of a 21-day cycle  
Pediatric dose: | Safety and efficacy in pediatric patients have not been established; not recommended for use in children  
Side effects: | Fa
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, specifically a DNA-binding agent
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of adult patients with metastatic small cell lung cancer (SCLC) who have progressed on or after platinum-based chemotherapy and at least one other line of therapy
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Immedica Pharma AB, Sweden
                    
                    
                    Package Size
                    1 Glass Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 33849.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        3.2 mg/m² administered as an intravenous infusion over 60 minutes on day 1 of a 21-day cycle
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy in pediatric patients have not been established; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Fatigue, nausea, vomiting, decreased appetite, constipation, anemia, thrombocytopenia, neutropenia, and increased liver enzymes
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to lurbinectedin or any component of the formulation; severe hepatic impairment (Child-Pugh Class C)
         
        
        
            
                Important Warnings
            
            Risk of myelosuppression, including severe neutropenia; monitor blood counts regularly; potential for hepatotoxicity; use caution in patients with hepatic impairment; risk of infusion-related reactions; avoid use in pregnancy due to potential fetal harm
         
        
        
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Antineoplastic agent, specifically a DNA-binding agent medicines available in UAE pharmacies
            
            
            
                Trabectedin
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.